Two Directors at Solvay SA bought 1,400 shares at between 28.700EUR and 28.840EUR. The significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
This conference book is your guide to our annual Benelux Local Champions Conference set to take place on Tuesday, 27 May 2025 at our historic building at Grand Place in Brussels. This event offers the possibility to have one-on-one meetings and/or small group meetings with the following Benelux companies and their top management & IR. ACKERMANS & VAN HAAREN | AGEAS | AHOLD DELHAIZE | AKZONOBEL | ARCADIS | AZELIS | CORBION | GBL | KBC GROUP | LOTUS BAKERIES | MELEXIS | PROXIMUS | SOFINA | UMIC...
Materialise to Hold Annual Shareholders’ Meeting and Extraordinary Shareholders’ Meeting on June 3, 2025 LEUVEN, Belgium, May 16, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders’ Meeting (AGM) on Tuesday, June 3, 2025, at 10:00 am CET. On the same date, Materialise will convene an Extraordinary Shareholders’ Meeting to discuss and vote on proposals to amend its articles of association (to renew the authorization of the Bo...
In this note we adjust our estimates as Alfen's 1Q25 results have once again fallen short of expectations. The outlook for the smart grid solutions segment, which was anticipated to be robust, disappointed. Despite investment plans highlighting labour shortages, the impact has been more severe than anticipated. Additionally, gross profit margins dynamics in the smart grid segment are well below our expectations. In the EV charging segment, public demand was low, while increased competition in th...
1Q25 was marked by a weak performance in Radiology Solutions (1Q is traditionally a seasonally weak quarter but now with strong impact of the decline of the medical film markets, particularly in China) and the continued strong performance of Agfa's HealthCare IT division, driven by customer adoption of Agfa's cloud technology. While Agfa's Digital Printing Solutions equipment business faced challenges due to economic uncertainty, and the market for Agfa's Zirfon membranes for green hydrogen prod...
The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market decline Regulated information May 14, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market decline Group performance: continued success of the strategic transformation Improved sales mix between growth engines and mature businesses and good cost control compensated for the negative impact of the market ...
De Agfa-Gevaert Groep in het eerste kwartaal van 2025: aangepaste EBITDA stabiel tegenover eerste kwartaal van 2024 – verbeterde mix en goede kostcontrole compenseerde voor de achteruitgang van de filmmarkt Gereglementeerde informatie 14 mei 2025 - 7:45 uur CET De Agfa-Gevaert Groep in het eerste kwartaal van 2025: aangepaste EBITDA stabiel tegenover eerste kwartaal van 2024 – verbeterde mix en goede kostcontrole compenseerde voor de achteruitgang van de filmmarkt Groepsprestatie: voortgezet succes van de strategische t...
Alfen has lowered both its FY25 revenue and adjusted EBITDA margin guidance. We cut our FY25F EBITDA estimate by 39%. Our old forecasts aimed at the mid-point of the former revenue guidance and we now aim at the low end of the new revenue guidance. With regards to the adjusted EBITDA margin guidance we aim below the low end of the new guidance as the gross margin mix works against Alfen. We change our recommendation from Buy to HOLD. The two ingredients for our prior bullish view were: (1) Posit...
Outcome of the 2025 Shareholders’ Meeting Press release Regulated information Shareholders expressed strong support for all resolutions, with an approval rate of over 90%. Brussels, May 13, 2025 - 5.45pm CEST Solvay held its Ordinary General Shareholders’ Meeting in Brussels, where all resolutions received strong shareholder support, exceeding 90% of votes, and included: The payment of a gross dividend of €2.43 per share for the year 2024. After deducting the interim dividend of €0.97 gross per share, paid on 22 January 202...
Résultats de l’assemblée générale des actionnaires 2025 Communiqué de presse Information réglementée Les actionnaires ont exprimé un fort soutien à toutes les résolutions, avec un taux d'approbation de plus de 90 %. Bruxelles, le 13 mai 2025 - 17h45 CEST Solvay a tenu son assemblée générale des actionnaires à Bruxelles, où toutes les résolutions ont reçu un fort soutien des actionnaires, dépassant 90% des voix, et comprenaient: le versement d’un dividende brut de 2,43 € par action pour l’année 2024. Après déduction de l'acompte sur...
Resultaat van de Algemene Vergadering van Aandeelhouders van 2025 Persbericht Gereglementeerde informatie Aandeelhouders spraken hun sterke steun uit voor alle resoluties, met een goedkeuringspercentage van meer dan 90% Brussel, 13 mei 2025 - 17u45 CEST Solvay hield zijn Algemene Vergadering van Aandeelhouders in Brussel en de aandeelhouders steunden nadrukkelijk alle resoluties, met meer dan 90% van de stemmen, waaronder: De uitbetaling van een brutodividend van €2,43 per aandeel voor het jaar 2024. Na aftrek van het interimdivi...
Annual General Meeting of Agfa-Gevaert NV - regulated information May 13, 2025 – 5.40 PM CET Regulated information Annual General Meeting of Agfa-Gevaert NV Mortsel, Belgium – May 13, 2025 – 5.40 p.m. CET At Agfa-Gevaert's Annual General Meeting, the 2024 financial statements, the allocation of the result, the remuneration report, the remuneration policy and the discharge of directors and statutory auditor were approved. Furthermore, the shareholders rendered available all share premiums that can be rendered available without specific formaliti...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.